TriSalus Life Sciences (TLSIW) Enterprise Value (2022 - 2025)
Historic Enterprise Value for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to -$22.7 million.
- TriSalus Life Sciences' Enterprise Value fell 10098.33% to -$22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.7 million, marking a year-over-year decrease of 10098.33%. This contributed to the annual value of -$8.5 million for FY2024, which is 2761.31% up from last year.
- Latest data reveals that TriSalus Life Sciences reported Enterprise Value of -$22.7 million as of Q3 2025, which was down 10098.33% from -$26.5 million recorded in Q2 2025.
- TriSalus Life Sciences' 5-year Enterprise Value high stood at -$50930.0 for Q1 2022, and its period low was -$26.5 million during Q2 2025.
- Moreover, its 4-year median value for Enterprise Value was -$9.4 million (2022), whereas its average is -$9.7 million.
- The largest annual percentage gain for TriSalus Life Sciences' Enterprise Value in the last 5 years was 4721.04% (2024), contrasted with its biggest fall of 1575092.57% (2024).
- Quarter analysis of 4 years shows TriSalus Life Sciences' Enterprise Value stood at -$9.4 million in 2022, then decreased by 25.1% to -$11.8 million in 2023, then increased by 27.61% to -$8.5 million in 2024, then crashed by 166.12% to -$22.7 million in 2025.
- Its Enterprise Value was -$22.7 million in Q3 2025, compared to -$26.5 million in Q2 2025 and -$13.0 million in Q1 2025.